These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The conundrum of neonatal coagulopathy. Revel-Vilk S Hematology Am Soc Hematol Educ Program; 2012; 2012():450-4. PubMed ID: 23233618 [TBL] [Abstract][Full Text] [Related]
5. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Strauss T; Sidlik-Muskatel R; Kenet G Semin Fetal Neonatal Med; 2011 Dec; 16(6):301-4. PubMed ID: 21810548 [TBL] [Abstract][Full Text] [Related]
6. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found. Diamond SL Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416 [TBL] [Abstract][Full Text] [Related]
7. Developmental hemostasis: relevance to hemostatic problems during childhood. Andrew M Semin Thromb Hemost; 1995; 21(4):341-56. PubMed ID: 8747697 [TBL] [Abstract][Full Text] [Related]
8. Reference intervals of citrated-native whole blood thromboelastography in premature neonates. Motta M; Guaragni B; Pezzotti E; Rodriguez-Perez C; Chirico G Early Hum Dev; 2017 Dec; 115():60-63. PubMed ID: 28923772 [TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor: at the crossroads of bleeding and thrombosis. Denis CV; Lenting PJ Int J Hematol; 2012 Apr; 95(4):353-61. PubMed ID: 22477538 [TBL] [Abstract][Full Text] [Related]
10. Intracranial Hemorrhages in Neonates: Incidence, Risk Factors, and Treatment. Andersson NG; Kenet G Semin Thromb Hemost; 2023 Jun; 49(4):409-415. PubMed ID: 36108647 [TBL] [Abstract][Full Text] [Related]
11. Developmental hemostasis: laboratory and clinical implications. Toulon P Int J Lab Hematol; 2016 May; 38 Suppl 1():66-77. PubMed ID: 27426861 [TBL] [Abstract][Full Text] [Related]
13. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247 [TBL] [Abstract][Full Text] [Related]
14. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Andrew M Semin Perinatol; 1997 Feb; 21(1):70-85. PubMed ID: 9190036 [TBL] [Abstract][Full Text] [Related]
15. Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia. Misgav M; Shenkman B; Budnik I; Einav Y; Martinowitz U Anesth Analg; 2011 May; 112(5):1034-40. PubMed ID: 21474661 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulation in preterm and term neonates: Why are they special? Bhat R; Monagle P Thromb Res; 2020 Mar; 187():113-121. PubMed ID: 31982841 [TBL] [Abstract][Full Text] [Related]
17. Principles of hemostasis in children: models and maturation. Guzzetta NA; Miller BE Paediatr Anaesth; 2011 Jan; 21(1):3-9. PubMed ID: 20849450 [TBL] [Abstract][Full Text] [Related]
18. Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Nowak-Göttl U; Limperger V; Kenet G; Degenhardt F; Arlt R; Domschikowski J; Clausnizer H; Liebsch J; Junker R; Steppat D Blood Cells Mol Dis; 2017 Sep; 67():2-13. PubMed ID: 28017497 [TBL] [Abstract][Full Text] [Related]